21 Dec, 2023 Our predictions for life sciences in 2024 By DLA Piper Life Sciences As the New Year is fast approaching, we asked members of our international Life Sciences team to share their predictions of what will be...
18 Dec, 2023 Transformative impact of Research and Development Block Exemptions By Richard Jenkinson Richard Jenkinson, a Senior Associate in our Competition Law Team, shares his insights on the transformative impact of Research and...
13 Dec, 2023 Experimental evidence in patent litigation – Rules for fair play By Rebecca Lawrence The technical nature of patent litigation means that experiments are often an essential (and sometimes the only) way to prove key aspects...
12 Dec, 2023 Uprooting Algorithmic Bias: How life sciences and healthcare organisations can minimise biased outcomes in the use of AI By Nicholas Tyacke Alex Horder Alexandra de Zwart Jordan Davis +1 more... Show less Artificial Intelligence (AI) is already altering the way we live and work, providing both opportunities to grow and challenges to...
08 Dec, 2023 Poland - Life Sciences Monthly Brief, November 2023 By Andrzej Balicki, Ph.D. Jolanta Dabrowicz Przemysław Matuszewski Urszula Grębowska +1 more... Show less Download a copy of our November monthly briefing, which covers key updates and insights in the following areas: Medicinal...
06 Dec, 2023 New bill establishing rules for clinical trials with humans and instituting the National Ethics System governing clinical research - Brazil By Bruna Rocha Juliana Marcondes Victoria Cristofaro Last Wednesday 29 November, the Chamber of Deputies approved Bill No. 7082/2017 (in Portuguese, “Projeto de Lei n° 7082/2017”), which...
04 Dec, 2023 Vapes banned from January 2024 under Australian reforms By Greg Bodulovic Nicholas Tyacke Tudor Filaret Hazel Pang Shawn Wang +2 more... Show less The Australian Federal Government has announced the first stage of Australia’s vaping reforms, which are set to commence on 1 January...